Evaluating smartwatch ECG against clinical ECG for childhood cancer survivors
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
This study is testing if a smartwatch ECG can predict heart problems just as well as a regular ECG for childhood cancer survivors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1300 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | St. Jude Children's Research Hospital Academic / other |
| Locations | 1 site (Memphis, Tennessee) |
| Trial ID | NCT05617391 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the effectiveness of a smartwatch ECG with a traditional clinical ECG in predicting cardiomyopathy risk among survivors of childhood cancer. Participants will undergo a 30-second ECG read from their smartwatch during a scheduled clinical appointment. The study also seeks to develop a predictive model based solely on smartwatch ECG data to enhance risk assessment for cardiomyopathy. By analyzing the concordance between the two ECG methods, the study hopes to improve remote monitoring of heart health in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 22 or older who are at least five years post-diagnosis of childhood cancer and are participants in the SJLIFE program.
Not a fit: Patients who have previously been diagnosed with cardiomyopathy or are currently on heart medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and monitoring of cardiomyopathy in childhood cancer survivors.
How similar studies have performed: While the use of smartwatch ECGs is a growing field, this specific approach of comparing smartwatch ECGs to clinical ECGs in childhood cancer survivors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * SJLIFE participant and 22 years of age or older at time of enrollment * Participant or legal guardian is able and willing to give informed consent * At least 5 years after childhood cancer diagnosis Exclusion Criteria: * Been diagnosed with cardiomyopathy on previous SJLIFE ECG * Currently on heart medication
Where this trial is running
Memphis, Tennessee
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Melissa Hudson, MD — St. Jude Children's Research Hospital
- Study coordinator: Melissa Hudson, MD
- Email: referralinfo@stjude.org
- Phone: 866-278-5833
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.